ASCEND BY NTHRYS
Research Abroad Products

Molecular Diagnostics Project Topics

Browse all focused areas across all project categories under this field.

Showing 61–72 of 200 project topics
Rapid Multiplex PCR Cartridge Platform for Emergency Settings
A plug-and-play molecular cartridge system integrating multiple pathogen detection assays into a single-use format that delivers results in under 15 minutes at the bedside. This platform enables emergency departments and urgent care facilities to monetize faster diagnostic workflows, reducing unnecessary hospitalizations and antibiotic misuse while commanding premium reimbursement rates.
Point-of-Care Molecular Diagnostic Development Click to view more details →
Cloud-Connected POCT Device Management and Data Analytics SaaS
A SaaS platform that aggregates real-time data from distributed point-of-care molecular devices, providing centralized quality control, inventory tracking, and predictive maintenance dashboards. This service generates recurring subscription revenue while enabling clinical networks to optimize device utilization, reduce downtime, and meet regulatory compliance requirements across multiple sites.
Point-of-Care Molecular Diagnostic Development Click to view more details →
Smartphone-Integrated Nucleic Acid Extraction and Detection Module
A compact, attachable molecular diagnostic module that converts standard smartphones into portable DNA/RNA testing instruments with integrated sample preparation and optical detection capabilities. This consumer-grade product opens direct-to-patient and telehealth revenue streams while reducing infrastructure costs for remote clinics and pharmacies.
Point-of-Care Molecular Diagnostic Development Click to view more details →
AI-Powered Assay Design and Optimization Software for IVD Manufacturers
An enterprise software tool that uses machine learning to accelerate molecular assay development, predicting primer efficacy, reducing cycle counts, and optimizing reaction conditions faster than traditional methods. IVD manufacturers license this platform to compress development timelines, decrease reagent costs, and rapidly launch competing products in emerging diagnostic markets.
Point-of-Care Molecular Diagnostic Development Click to view more details →
Integrated Waste-to-Result Lab-on-Chip Diagnostic Kits
A fully integrated microfluidic device that consolidates sample preparation, amplification, and detection into a single disposable chip, eliminating multi-step workflows and external equipment dependencies. This product generates high-margin consumable revenue through high-volume deployment in clinics, pharmacies, and decentralized testing networks with minimal operator training.
Point-of-Care Molecular Diagnostic Development Click to view more details →
Real-Time Molecular Surveillance Network for Outbreak Detection
A networked POCT platform with centralized epidemiological analytics that enables public health agencies and healthcare systems to track pathogen variants and resistance patterns in real time. This B2B service model generates revenue through government contracts, institutional subscriptions, and premium analytics tiers while positioning clients as leaders in infectious disease management.
Point-of-Care Molecular Diagnostic Development Click to view more details →
Multiplexed Antibiotic Resistance Genotyping Cartridge for Rapid Stewardship
A ready-to-use cartridge that simultaneously detects major antibiotic resistance genes and predicts susceptibility profiles in under 30 minutes directly from clinical samples. Hospitals and diagnostic labs monetize this through improved antimicrobial stewardship outcomes, reduced empiric therapy costs, and premium reimbursement for rapid resistance reporting.
Point-of-Care Molecular Diagnostic Development Click to view more details →
White-Label Molecular Testing Platform for Reference Laboratory Networks
A modular, fully customizable molecular diagnostic platform that regional labs and hospital networks can brand and deploy as their own POCT solution across multiple locations. This B2B licensing model generates recurring revenue through per-test royalties, platform maintenance fees, and value-added analytics while enabling partners to capture local market share.
Point-of-Care Molecular Diagnostic Development Click to view more details →
Portable Wastewater Surveillance Pathogen Detection System for Communities
A decentralized, field-deployable molecular diagnostic system that detects and quantifies circulating pathogens directly from wastewater, enabling early outbreak warning at the community level. Cities and public health agencies generate ROI through early intervention cost savings, environmental monitoring contracts, and licensing to wastewater treatment utilities.
Point-of-Care Molecular Diagnostic Development Click to view more details →
Federated Machine Learning Model for Diagnostic Accuracy Improvement Network
A privacy-preserving AI platform that aggregates anonymized molecular test results from distributed POCT devices to continuously refine diagnostic algorithms without centralizing sensitive data. This SaaS service generates subscription revenue while improving assay sensitivity and specificity across the entire network, creating competitive advantage and regulatory defensibility.
Point-of-Care Molecular Diagnostic Development Click to view more details →
Circulating Tumor DNA Detection SaaS Platform
A cloud-based platform that integrates ultra-sensitive ctDNA sequencing analysis with machine learning algorithms to detect cancer at early stages from blood samples. Enables oncology labs to offer non-invasive cancer screening services with recurring subscription revenue and premium reporting modules.
Liquid Biopsy Molecular Diagnostic Platforms Click to view more details →
Exosome Protein Biomarker Analysis Diagnostic Service
A commercial diagnostic service that isolates and analyzes cancer-derived exosome proteins from patient blood to predict treatment response and disease progression. Generates revenue through per-test fees, partnership agreements with pharmaceutical companies, and companion diagnostic licensing.
Liquid Biopsy Molecular Diagnostic Platforms Click to view more details →